Over 100 years ago, the gold mining industry of South Africa had a problem: too many workers were dying from pneumonia.

The 24 pathogen families listed in the reference tool include microorganisms that cause Covid-19 and Nipah virus, among ...

The vaccine protects against the serotypes responsible for the majority of adult invasive pneumococcal disease ...

Merck’s Capvaxive receives European approval for prevention of invasive pneumococcal disease and pneumococcal pneumonia in adults: Rahway, New Jersey Friday, March 28, 2025, 09: ...

The decision was influenced by the positive recommendation from the EMA’s Committee for Medicinal Products for Human Use.

Approves Merck’s CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) for Prevention of Invasive Pneumococcal Disease and ...

US pharma giant Merck & Co (NYSE: MRK) today announced that the European Commission (EC) has approved Capvaxive (Pneumococcal ...

Merck & Co. has won approval from the European Commission of its Capvaxive pneumococcal disease vaccine for adults. The Rahway, N.J., drugmaker on Wednesday said the approval covers the 21-valent ...

Merck (MRK), known as MSD outside of the United States and Canada, announced that the European Commission, or EC, has approved CAPVAXIVE, or ...

These findings demonstrate that the capsular serotype and genetic background significantly impact pneumococcal growth kinetics. The resultant growth features likely depend on the interaction between ...

Antibiotic-resistant bacteria is a serious public health threat. Understanding the biology of these bacteria--such as how they synthesise their protective capsules--is essential for developing new ...

Antibiotic-resistant bacteria is a serious public health threat. Understanding the biology of these bacteria -- such as how they synthesise their ...